Oral liquid levothyroxine solves the problem of tablet levothyroxine malabsorption due to concomitant intake of multiple drugs

References

• Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 2014;24:1670–1751.
   PubMed Web of Science ®Google Scholar
• Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43:55–68.
   PubMed Web of Science ®Google Scholar
• Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab. 2005;90:5483–5488.
   PubMed Web of Science ®Google Scholar
• Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: co-sponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012;22:1200–1235.
   PubMed Web of Science ®Google Scholar
• Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003;13:3–126.
   PubMed Web of Science ®Google Scholar
• Fiore E, Vitti P. Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease. J Clin Endocrinol Metab. 2012;97:1134–1145.
   PubMed Web of Science ®Google Scholar
• Jonklaas J. Update on the treatment of hypothyroidism. Curr Opin Oncol. 2016;28:18–25.
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. American Thyroid Association Management Guidelines for Adult Patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2015;2016(26):1–133.
   Google Scholar
• Medicines Use and Spending Shifts. A Review of the Use of Medicines in the U.S. in 2014 https://www.imshealth.com/files/web/IMSH%20Institute/Reports/Medicines_Use_and_Spending_Shifts/Medicine-Spending-and-Growth_1995-2014.pdf Accessed 12 November 2016.
   Google Scholar
• Vita R, Fallahi P, Antonelli A, et al. The administration of L-thyroxine as soft gel capsule or liquid solution. Expert Opin Drug Deliv. 2014;11:1103–1111.
   PubMed Web of Science ®Google Scholar
• Centanni M, Gargano L, Canettieri G, et al. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med. 2006;354:1787–1795.
   PubMed Web of Science ®Google Scholar
• Benvenga S, Bartolone L, Squadrito S, et al. Delayed intestinal absorption of levothyroxine. Thyroid. 1995;5:249–253.
   PubMed Web of Science ®Google Scholar
• Liwampo L, Hershman JM. Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab. 2009;23:781–792.
   PubMed Web of Science ®Google Scholar
• Colucci P, Seng Yue C, Ducharme M, et al. A review of the pharmacokinetics of levothyroxine for the treatment of hypothyroidism. Eur Endocrinol. 2013;9:40–47.
   PubMedGoogle Scholar
• Benvenga S. When thyroid hormone replacement is ineffective? Curr Opin Endocrinol Diabetes Obes. 2013;20:467–477.
   PubMed Web of Science ®Google Scholar
• Cassio A, Monti S, Rizzello A, et al. Comparison between liquid and tablet formulations of levothyroxine in the initial treatment of congenital hypothyroidism. J Pediatr. 2013;162:1264–1269.
   PubMed Web of Science ®Google Scholar
• Peroni E, Vigone MC, Mora S, et al. Congenital hypothyroidism treatment in infants: a comparative study between liquid and tablet formulations of levothyroxine. Horm Res Paediatr. 2014;81:50–54.
   PubMed Web of Science ®Google Scholar
• Yue CS, Scarsi C, Ducharme MP. Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms. Arzneimittelforschung. 2012;62:631–636.
   PubMed Web of Science ®Google Scholar
• Vita R, Saraceno G, Trimarchi F, et al. Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors. J Clin Endocrinol Metab. 2014;99:4481–4486.
   PubMed Web of Science ®Google Scholar
• Taylor PN, Iqbal A, Minassian C, et al. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study. JAMA Intern Med. 2014;174:32–39.
   PubMed Web of Science ®Google Scholar
• Kung AW, Yeung SS. Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin. J Clin Endocrinol Metab. 1996;81:1232–1236.
   PubMed Web of Science ®Google Scholar
• Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA. 2000;283:2822–2825.
   PubMed Web of Science ®Google Scholar
• Schneyer CR. Calcium carbonate and reduction of levothyroxine efficacy [letter]. JAMA. 1998;279:750.
   PubMed Web of Science ®Google Scholar
• Campbell NR, Hasinoff BB, Stalts H, et al. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med. 1992;117:1010–1013.
   PubMed Web of Science ®Google Scholar
• Fiaux E, Kadri K, Levasseur C, et al. Hypothyroidism as the result of drug interaction between ferrous sulfate and levothyroxine. Rev Med Interne. 2010;31:e4–5.
   PubMedGoogle Scholar
• Shakir KM, Chute JP, Aprill BS, et al. Ferrous sulfate-induced increase in requirement for thyroxine in a patient with primary hypothyroidism. South Med J. 1997;90:637–639.
   PubMed Web of Science ®Google Scholar
• Iovino M, Iovine N, Petrosino A, et al. Sevelamer carbonate markedly reduces levothyroxine absorption. Endocr Metab Immune Disord Drug Targets. 2014;14:206–209.
   PubMed Web of Science ®Google Scholar
• Arnadottir M, Johannesson A. Phosphate binders and timing of levothyroxine administration. Nephrol Dial Transplant. 2008;23:420.
   PubMed Web of Science ®Google Scholar
• Diskin CJ, Stokes TJ, Dansby LM, et al. Effect of phosphate binder upon TSH and L-thyroxine dose in patients on thyroid replacement. Int Urol Nephrol. 2007;39:599–602.
   PubMed Web of Science ®Google Scholar
• Sperber AD, Liel Y. Evidence for interference with the intestinal absorption of levothyroxine sodium by aluminum hydroxide. Arch Intern Med. 1992;152:183–184.
   PubMedGoogle Scholar
• Benvenga S, Bartolone L, Pappalardo MA, et al. Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid. 2008;18:293–301.
   PubMed Web of Science ®Google Scholar
• Mersebach H, Rasmussen AK, Kirkegaard L, et al. Intestinal adsorption of levothyroxine by antacids and laxatives: case stories and in vitro experiments. Pharmacol Toxicol. 1999;84:107–109.
   PubMedGoogle Scholar
• Liel Y, Sperber AD, Shany S. Nonspecific intestinal adsorption of levothyroxine by aluminum hydroxide. Am J Med. 1994;97:363–365.
   PubMed Web of Science ®Google Scholar
• Zentilin P, Dulbecco P, Savarino E, et al. An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry. Aliment Pharmacol Ther. 2005;21:29–34.
   PubMed Web of Science ®Google Scholar
• Vita R, Saraceno S, Trimarchi F, et al. Levothyroxine oral solution solves the problem of impaired absorption due to calcium and iron salts. MON-0531. Endocrine Society’s 96th Annual Meeting and Expo; 2014 Jun 21–24; Chicago, IL, USA.
   Google Scholar
• Linnoila M, Mattila MJ, Kitchell BS. Drug interactions with alcohol. Drugs. 1979;18:299–311.
   PubMed Web of Science ®Google Scholar